Dyadic International (DYAI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.41, -2.12% vs the prior close of $0.42.
- Volume 78.28K shares, 0.4x its 50-day average (light).
- New SEC filings: SCHEDULE 13G (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
DYAI dips 2.1% to $0.41. Closed at $0.41, -2.12% vs the prior close of $0.42. Day range $0.39–$0.43, opened at $0.42.
DYAI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DYAI dips 2.1% to $0.41
- Closed at $0.41, -2.12% vs the prior close of $0.42. Day range $0.39–$0.43, opened at $0.42.
- Volume was 78.28K shares, 0.4x its 50-day average of 180.81K — lighter than usual.
- Price is -26.1% vs its 50-day average ($0.56) and -47.8% vs its 200-day average ($0.79).
- 52-week range $0.34–$1.60; today's close sits at 6% of that range, 74.3% below the 52-week high.
Oct 15, 2026 — DYAI rises 2.4% to $0.42 on 2.8x normal volume
- Closed at $0.42, +2.44% vs the prior close of $0.41. Day range $0.40–$0.48, opened at $0.41.
- Volume was 508.80K shares, 2.8x its 50-day average of 180.17K — unusually heavy trading.
- Price is -26.1% vs its 50-day average ($0.57) and -46.9% vs its 200-day average ($0.79).
- 52-week range $0.34–$1.60; today's close sits at 6% of that range, 73.8% below the 52-week high.
Oct 14, 2026 — DYAI slides 4.7% to $0.41
- Closed at $0.41, -4.65% vs the prior close of $0.43. Day range $0.41–$0.43, opened at $0.43.
- Volume was 36.00K shares, 0.2x its 50-day average of 181.11K — lighter than usual.
- Price is -29.3% vs its 50-day average ($0.58) and -48.3% vs its 200-day average ($0.79).
- 52-week range $0.34–$1.60; today's close sits at 6% of that range, 74.4% below the 52-week high.
Oct 13, 2026 — DYAI rises 2.4% to $0.43
- Closed at $0.43, +2.38% vs the prior close of $0.42. Day range $0.40–$0.43, opened at $0.43.
- Volume was 47.40K shares, 0.3x its 50-day average of 181.23K — lighter than usual.
- Price is -27.5% vs its 50-day average ($0.59) and -46.0% vs its 200-day average ($0.80).
- 52-week range $0.34–$1.60; today's close sits at 7% of that range, 73.1% below the 52-week high.
Oct 12, 2026 — DYAI slides 4.5% to $0.42, 3 down days in a row
- Closed at $0.42, -4.55% vs the prior close of $0.44. Day range $0.42–$0.47, opened at $0.47.
- Volume was 33.40K shares, 0.2x its 50-day average of 183.02K — lighter than usual.
- Price is -30.6% vs its 50-day average ($0.61) and -47.4% vs its 200-day average ($0.80).
- 52-week range $0.34–$1.60; today's close sits at 6% of that range, 73.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — DYAI ends flat (+0.0%) to $0.44
- Closed at $0.44, +0.00% vs the prior close of $0.44. Day range $0.44–$0.47, opened at $0.45.
- Volume was 12.00K shares, 0.1x its 50-day average of 185.87K — lighter than usual.
- Price is -28.8% vs its 50-day average ($0.62) and -45.1% vs its 200-day average ($0.80).
- 52-week range $0.34–$1.60; today's close sits at 8% of that range, 72.5% below the 52-week high.
Oct 8, 2026 — DYAI slides 4.3% to $0.44
- Closed at $0.44, -4.35% vs the prior close of $0.46. Day range $0.44–$0.46, opened at $0.46.
- Volume was 119.30K shares, 0.6x its 50-day average of 185.10K.
- Price is -30.2% vs its 50-day average ($0.63) and -45.3% vs its 200-day average ($0.80).
- 52-week range $0.34–$1.60; today's close sits at 8% of that range, 72.5% below the 52-week high.
Oct 7, 2026 — DYAI rises 2.2% to $0.46
- Closed at $0.46, +2.22% vs the prior close of $0.45. Day range $0.45–$0.49, opened at $0.45.
- Volume was 123.90K shares, 0.7x its 50-day average of 189.69K.
- Price is -28.5% vs its 50-day average ($0.64) and -43.0% vs its 200-day average ($0.81).
- 52-week range $0.34–$1.60; today's close sits at 10% of that range, 71.2% below the 52-week high.
Oct 6, 2026 — DYAI ends flat (+0.0%) to $0.45
- Closed at $0.45, +0.00% vs the prior close of $0.45. Day range $0.45–$0.49, opened at $0.47.
- Volume was 30.30K shares, 0.2x its 50-day average of 191.34K — lighter than usual.
- Price is -31.3% vs its 50-day average ($0.66) and -44.4% vs its 200-day average ($0.81).
- 52-week range $0.34–$1.60; today's close sits at 9% of that range, 71.9% below the 52-week high.
Oct 5, 2026 — DYAI dips 2.2% to $0.45
- Closed at $0.45, -2.17% vs the prior close of $0.46. Day range $0.44–$0.48, opened at $0.46.
- Volume was 142.90K shares, 0.7x its 50-day average of 190.59K.
- Price is -32.7% vs its 50-day average ($0.67) and -44.5% vs its 200-day average ($0.81).
- 52-week range $0.34–$1.60; today's close sits at 9% of that range, 71.9% below the 52-week high.
Oct 2, 2026 — DYAI jumps 7.0% to $0.46
- Closed at $0.46, +6.98% vs the prior close of $0.43. Day range $0.44–$0.49, opened at $0.46.
- Volume was 142.20K shares, 0.7x its 50-day average of 193.15K.
- Price is -32.7% vs its 50-day average ($0.68) and -43.5% vs its 200-day average ($0.81).
- 52-week range $0.34–$1.60; today's close sits at 10% of that range, 71.2% below the 52-week high.
DYAI latest news & SEC filings
Every SEC filing by or about DYAI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 18, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 18, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 11, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $961.14K (prior year $966.63K) (-0.6% vs Jun 30, 2025)
- Net income: -$2.12M (prior year -$1.79M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.06 (prior year -$0.06) ( vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Francisco Trust Under Agreement Dated February 28, 1996 sold 2,616 shares at $1.21 (≈$3.17K) on Jul 24, 2026
- Francisco Trust Under Agreement Dated February 28, 1996 sold 2,616 shares at $1.21 (≈$3.17K) on Jul 24, 2026
- Francisco Trust Under Agreement Dated February 28, 1996 sold 2,616 shares at $1.21 (≈$3.17K) on Jul 24, 2026
- Francisco Trust Under Agreement Dated February 28, 1996 sold 2,616 shares at $1.21 (≈$3.17K) on Jul 24, 2026
- Francisco Trust Under Agreement Dated February 28, 1996 sold 54,760 shares at $1.30 (≈$71.19K) on Jul 23, 2026
- Francisco Trust Under Agreement Dated February 28, 1996 sold 54,760 shares at $1.30 (≈$71.19K) on Jul 23, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 21, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Francisco Trust Under Agreement Dated February 28, 1996 sold 15,000 shares at $2.01 (≈$30.15K) on Jan 7, 2025
- Francisco Trust Under Agreement Dated February 28, 1996 sold 15,000 shares at $2.01 (≈$30.15K) on Jan 7, 2025
- Francisco Trust Under Agreement Dated February 28, 1996 sold 15,000 shares at $2.01 (≈$30.15K) on Jan 7, 2025
- Francisco Trust Under Agreement Dated February 28, 1996 sold 15,000 shares at $2.01 (≈$30.15K) on Jan 7, 2025
- Francisco Trust Under Agreement Dated February 28, 1996 sold 20,000 shares at $1.92 (≈$38.40K) on Jan 6, 2025
- Francisco Trust Under Agreement Dated February 28, 1996 sold 20,000 shares at $1.92 (≈$38.40K) on Jan 6, 2025
- …plus 7 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade DYAI
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.58% (largest 11.9%). That is a volatile stock.
- Liquidity: about 133.31K shares (≈$54.81K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.41 vs a range of $0.34–$1.60 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Trust Under Agreement Dated February 28, 1996 Francisco sold 2,616 shares on Jul 24, 2026.
- Latest filings: 8-K Sep 25, 2026; 8-K Aug 14, 2026; 10-Q Aug 12, 2026.
- Share count: 36.44M shares outstanding (Aug 11, 2026), +0.7% vs a year earlier.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
DYAI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.42 | 0.43 | 0.39 | 0.41 | 78.28K |
| Oct 15, 2026 | 0.41 | 0.48 | 0.40 | 0.42 | 508.80K |
| Oct 14, 2026 | 0.43 | 0.43 | 0.41 | 0.41 | 36.00K |
| Oct 13, 2026 | 0.43 | 0.43 | 0.40 | 0.43 | 47.40K |
| Oct 12, 2026 | 0.47 | 0.47 | 0.42 | 0.42 | 33.40K |
| Oct 9, 2026 | 0.45 | 0.47 | 0.44 | 0.44 | 12.00K |
| Oct 8, 2026 | 0.46 | 0.46 | 0.44 | 0.44 | 119.30K |
| Oct 7, 2026 | 0.45 | 0.49 | 0.45 | 0.46 | 123.90K |
| Oct 6, 2026 | 0.47 | 0.49 | 0.45 | 0.45 | 30.30K |
| Oct 5, 2026 | 0.46 | 0.48 | 0.44 | 0.45 | 142.90K |
| Oct 2, 2026 | 0.46 | 0.49 | 0.44 | 0.46 | 142.20K |
| Oct 1, 2026 | 0.44 | 0.45 | 0.43 | 0.43 | 82.60K |
| Sep 30, 2026 | 0.49 | 0.50 | 0.44 | 0.44 | 85.90K |
| Sep 29, 2026 | 0.44 | 0.48 | 0.44 | 0.47 | 116.70K |
| Sep 28, 2026 | 0.44 | 0.48 | 0.42 | 0.47 | 307.10K |
| Sep 25, 2026 | 0.44 | 0.46 | 0.40 | 0.42 | 141.40K |
| Sep 24, 2026 | 0.41 | 0.46 | 0.41 | 0.44 | 122.00K |
| Sep 23, 2026 | 0.41 | 0.43 | 0.38 | 0.41 | 251.30K |
| Sep 22, 2026 | 0.42 | 0.44 | 0.40 | 0.40 | 194.50K |
| Sep 21, 2026 | 0.40 | 0.43 | 0.39 | 0.40 | 90.30K |
About Dyadic International
Dyadic International (DYAI) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in JUPITER, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1213809.
DYAI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mark A Emalfarb | CEO | Jan 6, 2026 |
| Seth Herbst | Director | Jan 6, 2026 |
| Jack Kaye | Director | Jan 6, 2026 |
| Patrick K. Lucy | Director | Jan 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mark A Emalfarb | CEO | Jan 6, 2026 |
| Joseph P Hazelton | President & COO | Jan 6, 2026 |
| Ping Wang Rawson | Chief Financial Officer | Jan 6, 2026 |
| Ronen Tchelet | VP of Research and Bus. Dvlpmt | Jan 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 24, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 2,616 | $1.21 |
| Jul 24, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 2,616 | $1.21 |
| Jul 24, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 2,616 | $1.21 |
| Jul 24, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 2,616 | $1.21 |
| Jul 23, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 54,760 | $1.30 |
| Jul 23, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 54,760 | $1.30 |
| Jul 23, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 54,760 | $1.30 |
| Jul 23, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 54,760 | $1.30 |
| Jul 22, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 38,016 | $1.33 |
| Jul 22, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 38,016 | $1.33 |
| Jul 22, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 38,016 | $1.33 |
| Jul 22, 2026 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 38,016 | $1.33 |
| Jan 7, 2025 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 15,000 | $2.01 |
| Jan 7, 2025 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 15,000 | $2.01 |
| Jan 7, 2025 | Trust Under Agreement Dated February 28, 1996 Francisco | Sale | 15,000 | $2.01 |
DYAI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.09M | $-7.36M | -0.23 | $-5.70M |
| Dec 31, 2024 | $3.50M | $-5.81M | -0.20 | $-3.97M |
| Dec 31, 2023 | $2.90M | $-6.80M | — | $-6.73M |
| Dec 31, 2022 | $2.93M | $-9.74M | — | $-8.08M |
| Dec 31, 2021 | $2.40M | $-13.07M | — | $-11.28M |
Latest balance sheet: total assets $6.54M, total liabilities $8.92M, cash $1.43M (as of Jun 30, 2026).
DYAI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $0.88 |
| May 13, 2026 | 8-K Item 2.02 (results) | $0.71 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $0.87 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $0.94 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $0.82 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.04 |
| Mar 26, 2025 | 8-K Item 2.02 (results) | $1.33 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $1.14 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DYAI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.